DK0885010T3 - Pulverformigt lægemiddel indeholdende intercellulært adhæsionsmolekyle - Google Patents
Pulverformigt lægemiddel indeholdende intercellulært adhæsionsmolekyleInfo
- Publication number
- DK0885010T3 DK0885010T3 DK97907981T DK97907981T DK0885010T3 DK 0885010 T3 DK0885010 T3 DK 0885010T3 DK 97907981 T DK97907981 T DK 97907981T DK 97907981 T DK97907981 T DK 97907981T DK 0885010 T3 DK0885010 T3 DK 0885010T3
- Authority
- DK
- Denmark
- Prior art keywords
- sicam
- adhesion molecule
- amount
- drug containing
- intercellular adhesion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1294496P | 1996-03-06 | 1996-03-06 | |
PCT/US1997/003263 WO1997032596A1 (en) | 1996-03-06 | 1997-03-04 | Intercellular adhesion molecule powder formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0885010T3 true DK0885010T3 (da) | 2003-09-15 |
Family
ID=21757501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97907981T DK0885010T3 (da) | 1996-03-06 | 1997-03-04 | Pulverformigt lægemiddel indeholdende intercellulært adhæsionsmolekyle |
Country Status (8)
Country | Link |
---|---|
US (1) | US6365343B1 (da) |
EP (1) | EP0885010B1 (da) |
JP (1) | JP2000507221A (da) |
AT (1) | ATE242001T1 (da) |
CA (1) | CA2244894A1 (da) |
DE (1) | DE69722594T2 (da) |
DK (1) | DK0885010T3 (da) |
WO (1) | WO1997032596A1 (da) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4493594B2 (ja) * | 2003-03-04 | 2010-06-30 | 田辺三菱製薬株式会社 | 粉末経鼻投与製剤 |
WO2004100929A1 (en) | 2003-05-12 | 2004-11-25 | Synergia Pharma, Inc. | Threo-dops controlled release formulation |
US8158149B2 (en) * | 2004-05-12 | 2012-04-17 | Chelsea Therapeutics, Inc. | Threo-DOPS controlled release formulation |
GB2420707A (en) * | 2004-10-11 | 2006-06-07 | Nasaleze Patents Ltd | Compositions for intranasal administration |
KR20100059859A (ko) * | 2007-09-11 | 2010-06-04 | 몬도바이오테크 래보래토리즈 아게 | 치료제로서의 c형 나트륨이뇨 펩티드 단독 또는 뉴로펩티드 af와의 배합물의 용도 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0362531B1 (en) * | 1988-09-01 | 1999-11-10 | Bayer Corporation | A human rhinovirus receptor protein that inhibits virus infectivity |
US5235049A (en) * | 1989-01-24 | 1993-08-10 | Molecular Therapeutics, Inc. | Nucleic acid sequences encoding a soluble molecule (SICAM-1) related to but distinct from ICAM-1 |
CA2008368C (en) * | 1989-01-24 | 2003-04-08 | Jeffrey Greve | Soluble molecule related to but distinct from icam-1 |
DK0745852T3 (da) * | 1989-03-16 | 2002-10-14 | Blood Res Center | Anvendelse af funktionelle derivater af intercellulær adhæsion-molekylet ICAM-1 i antiviral terapi |
WO1991018010A1 (en) * | 1990-05-15 | 1991-11-28 | Swinburne Limited | Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof |
GB9414966D0 (en) * | 1994-07-26 | 1994-09-14 | Danbiosyst Uk | Pharmaceutical compositions for the nasal administration of antiviral agents |
US5879712A (en) | 1995-06-07 | 1999-03-09 | Sri International | Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced |
-
1997
- 1997-03-04 EP EP97907981A patent/EP0885010B1/en not_active Expired - Lifetime
- 1997-03-04 JP JP9531863A patent/JP2000507221A/ja not_active Ceased
- 1997-03-04 DE DE69722594T patent/DE69722594T2/de not_active Expired - Fee Related
- 1997-03-04 AT AT97907981T patent/ATE242001T1/de not_active IP Right Cessation
- 1997-03-04 CA CA002244894A patent/CA2244894A1/en not_active Abandoned
- 1997-03-04 DK DK97907981T patent/DK0885010T3/da active
- 1997-03-04 US US09/117,087 patent/US6365343B1/en not_active Expired - Lifetime
- 1997-03-04 WO PCT/US1997/003263 patent/WO1997032596A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CA2244894A1 (en) | 1997-09-12 |
ATE242001T1 (de) | 2003-06-15 |
EP0885010A1 (en) | 1998-12-23 |
JP2000507221A (ja) | 2000-06-13 |
US6365343B1 (en) | 2002-04-02 |
WO1997032596A1 (en) | 1997-09-12 |
DE69722594D1 (de) | 2003-07-10 |
EP0885010B1 (en) | 2003-06-04 |
DE69722594T2 (de) | 2004-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU57600A (sh) | Derivarti biciklične hidroksaminske kiseline | |
NO984376D0 (no) | Mikrosfµrer av polysakkarid for administrering av medikamenter til lungene | |
BR9803300A (pt) | Formulação farmacêutica. | |
MD1813B2 (en) | Purified cyclodextrin derivatives of sulphoalkyl ethers or mixtures thereof, clathrate complex of cyclodextrin derivatives with medicamental content and pharmaceutical composition | |
AU9062998A (en) | Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids) | |
CO5271759A1 (es) | Formulacion en solucion que contiene una mezcla de disolventes | |
SE9700135D0 (sv) | New formulation | |
GB2332147A (en) | Therapeutically active compositions | |
EP0679390A3 (en) | Sprayable topical pharmaceutical compositions | |
NZ505919A (en) | Nasal solutions | |
IS2789B (is) | Lyfjablöndur sem innihalda mónóamínoxídasa B hemla | |
DK0460062T3 (da) | Huperzin A-analoger | |
IS5110A (is) | Ný lyfjablanda til innöndunar með eðlisþyngd í lausu sem er frá 0,28 til 0,38 g/ml, sem inniheldur búdesóníð | |
ID28510A (id) | Formulasi oral yang baru untuk agonis atau antagonis 5-ht4 | |
PT975348E (pt) | Composicoes de tibolona estabilizadas | |
NO20005332L (no) | 1,6-GPS-(6-O-α-D-glukopyranosyl-D-sorbit) og 1,1-GPM-(1-O-α-D-glukopyranosyl-D-mannit)-holdig sukkeralkoholblanding for bruk som terapeutisk aktivt stoff samt legemiddel inneholdende nevnte blanding | |
DK0885010T3 (da) | Pulverformigt lægemiddel indeholdende intercellulært adhæsionsmolekyle | |
NO20012351L (no) | Farmasoytisk sammensetning for modifisert frigjoring av insulinsensibiliserende middel | |
CA2417935A1 (en) | Anti-inflammatory medicament | |
ATE353224T1 (de) | Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz | |
HUP0000882A2 (hu) | NMDA (N-metil-D-aszpartát) antagonista hatású indolszármazékok, valamint a vegyületeket tartalmazó gyógyszerkészítmények | |
AU7470098A (en) | Antithrombotic agents | |
TR200102087T2 (tr) | Yeni morfolinbenzamid tuzları | |
EP1022017A3 (de) | Kosmetische oder pharmazeutische Zubereitungen für die topische Verabreichung mit verbesserter Stabilität | |
ATE194498T1 (de) | Wasserfreies mittel auf lactulosebasis |